RSN: FOCUS: Coronavirus Vaccine Trial by Moderna Shows Promising Early Results

18 May 20

It's Live on the HomePage Now:
Reader Supported News

WITH THE MONEY YOU DONATE WE PAY PEOPLE: When you donate to RSN we use that money to pay people for their work. Having a budget allows us to pass along to the contributors and those who work to make the project stronger fair wages. It’s not optional. Having a budget is required. Think of it as a “fair-trade” publishing. This is the publication that the Readers built. Never forget that. / Marc Ash, Founder Reader Supported News

Sure, I'll make a donation!

---

FOCUS: Coronavirus Vaccine Trial by Moderna Shows Promising Early Results

Carolyn Y. Johnson, The Washington Post
Johnson writes: "Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its first human safety tests Monday."
READ MORE

---

Contribute to RSN 

Update My Monthly Donation